[go: up one dir, main page]

ES2036457A1 - Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion. - Google Patents

Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.

Info

Publication number
ES2036457A1
ES2036457A1 ES919101560A ES9101560A ES2036457A1 ES 2036457 A1 ES2036457 A1 ES 2036457A1 ES 919101560 A ES919101560 A ES 919101560A ES 9101560 A ES9101560 A ES 9101560A ES 2036457 A1 ES2036457 A1 ES 2036457A1
Authority
ES
Spain
Prior art keywords
dosage form
pharmaceutical dosage
release oral
programmed release
solid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES919101560A
Other languages
English (en)
Other versions
ES2036457B1 (es
Inventor
Franco Pozzi
Pia Furlani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT02084990A external-priority patent/IT1244867B/it
Priority claimed from IT02244290A external-priority patent/IT1244037B/it
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of ES2036457A1 publication Critical patent/ES2036457A1/es
Application granted granted Critical
Publication of ES2036457B1 publication Critical patent/ES2036457B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORMA DE DOSIFICACION FARMACEUTICA ORAL DE LIBERACION PROGRAMADA Y PROCEDIMIENTO DE PREPARACION. LA FORMA DE DOSIFICACION COMPRENDE UN NUCLEO ORALMENTE ADMINISTRABLE QUE CONTIENE EL INGREDIENTE ACTIVO, REVESTIDO POR UNA CAPA DE MATERIAL HIDROFOBICO, CON PUNTO DE FUSION ENTRE 50GC Y 90GC, UN TENSIOACTIVO CON HLB ENTRE 10 Y 16, Y OPCIONALMENTE UN MATERIAL FORMADOR DE PELICULA ACUOSOLUBLE. ESTAS FORMAS DE DOSIFICACION SE EMPLEAN PARA LIBERAR EL INGREDIENTE ACTIVO DESPUES DE UN INTERVALO DE NO LIBERACION PREESTABLECIDO QUE NO DEPENDE DE FACTORES FISIOLOGICOS.
ES9101560A 1990-07-04 1991-07-03 Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion. Expired - Fee Related ES2036457B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02084990A IT1244867B (it) 1990-07-04 1990-07-04 Forma farmaceutica a rilascio rapido ritardato
IT02244290A IT1244037B (it) 1990-12-19 1990-12-19 Forma farmaceutica a rilascio selettivo nel colon

Publications (2)

Publication Number Publication Date
ES2036457A1 true ES2036457A1 (es) 1993-05-16
ES2036457B1 ES2036457B1 (es) 1994-03-01

Family

ID=26327684

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9101560A Expired - Fee Related ES2036457B1 (es) 1990-07-04 1991-07-03 Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.

Country Status (23)

Country Link
US (3) US5310558A (es)
JP (1) JPH0624961A (es)
AT (1) AT400295B (es)
AU (1) AU638583B2 (es)
BE (1) BE1004882A3 (es)
CA (1) CA2044398C (es)
CH (1) CH683498A5 (es)
DE (1) DE4122039A1 (es)
DK (1) DK129591A (es)
ES (1) ES2036457B1 (es)
FI (1) FI109874B (es)
FR (1) FR2664163B1 (es)
GB (1) GB2245492B (es)
GR (1) GR1002564B (es)
HU (2) HUT59591A (es)
IE (1) IE61651B1 (es)
IL (1) IL98525A (es)
LU (1) LU87964A1 (es)
NL (1) NL9101161A (es)
NO (1) NO304579B1 (es)
PT (1) PT98188B (es)
RU (1) RU2012330C1 (es)
SE (1) SE512373C2 (es)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
US6482516B1 (en) * 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
AU3949093A (en) * 1992-03-31 1993-11-08 Benzon Pharma A/S A pharmaceutical formulation
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
FR2723536A1 (fr) * 1994-08-11 1996-02-16 Seth Pawan Composition permettant une liberation selective d'un principe actif
EP0742008A1 (en) * 1995-05-11 1996-11-13 Euro-Celtique S.A. Controlled release pharmaceutical formulations
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EP0846755B1 (en) * 1996-12-06 2007-12-05 The Procter & Gamble Company Coated detergent tablet
WO1998026767A2 (en) * 1996-12-17 1998-06-25 Poli Industria Chimica S.P.A. Site-specific controlled release dosage formulation for mesalamine
US5914134A (en) * 1997-01-27 1999-06-22 Wockhardt Europe Limited Process for the pulsatile delivery of diltiazem HCL and product produced thereby
NL1005948C2 (nl) * 1997-05-01 1998-11-09 Inst Voor Agrotech Onderzoek Omhulde stof met gecontroleerde afgifte.
NL1007696C1 (nl) * 1997-05-01 1998-11-03 Inst Voor Agrotech Onderzoek Omhulde stof met gecontroleerde afgifte.
ZA984591B (en) * 1997-06-09 1998-12-08 Ambi Inc A method for the treatment of diarrheal disease and for elmininating particular bacterial populations from the colon
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
KR100501022B1 (ko) * 1998-07-28 2005-07-18 다나베 세이야꾸 가부시키가이샤 장내 적소 방출형 제제
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US20090297597A1 (en) * 1998-11-02 2009-12-03 Gary Liversidge Modified Release Ticlopidine Compositions
US20070122481A1 (en) * 1998-11-02 2007-05-31 Elan Corporation Plc Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer
HU230454B1 (hu) * 1998-11-02 2016-07-28 Alkermes Pharma Ireland Limited Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
US6217904B1 (en) * 1999-04-06 2001-04-17 Pharmaquest Ltd. Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant
HK1046098A1 (zh) * 1999-06-07 2002-12-27 南诺斯菲尔股份有限公司 包被颗粒的方法以及所得颗粒
ITMI991316A1 (it) * 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
WO2001032148A1 (en) 1999-10-29 2001-05-10 Euro-Celtique, S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP1252887A4 (en) 2000-01-27 2009-07-29 Mitsubishi Tanabe Pharma Corp PREPARATION WITH EXTENDED RELEASE AND PROCESS FOR THEIR PREPARATION
AU2001237424A1 (en) * 2000-02-28 2001-09-12 Akzo Nobel N.V. Bodies for the controlled release of active substances
AU2001234005B2 (en) * 2000-02-28 2006-01-19 Pharmakodex Limited Improvements in or relating to the delivery of oral drugs
DE10012199A1 (de) * 2000-03-13 2001-09-20 Haarmann & Reimer Gmbh Eingekapselte Substanzen mit kontrollierter Freisetzung
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
WO2001091784A1 (en) * 2000-05-26 2001-12-06 C.T.P. Cable Technology Procurement Ag Means for maintenance and/or correction of glucose concentration in blood
ES2185452B2 (es) * 2000-08-01 2004-03-16 Cinfa S A Lab Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
CN101317825A (zh) 2000-10-30 2008-12-10 欧罗赛铁克股份有限公司 控释氢可酮制剂
EP1368000A4 (en) * 2001-03-13 2004-12-01 Penwest Pharmaceuticals Co CHRONOTHERAPEUTIC PHARMACEUTICAL FORMS CONTAINING A GLUCOCORTICOSTEROID
US8218183B2 (en) * 2001-07-31 2012-07-10 Transpacific Systems, Llc Scanning speed control device and method
US7248387B2 (en) 2001-07-31 2007-07-24 Umax Data Systems, Inc. Scanning speed control device and method
US6500454B1 (en) 2001-10-04 2002-12-31 Eurand Pharmaceuticals Ltd. Timed, sustained release systems for propranolol
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP4031232B2 (ja) * 2001-11-09 2008-01-09 カプスゲル・ジャパン株式会社 新規カプセル
ITMI20012599A1 (it) * 2001-12-11 2003-06-11 Cosmo Spa Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
US9308220B2 (en) 2001-12-11 2016-04-12 Cosmo Technologies Limited Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
US6663888B2 (en) 2001-12-14 2003-12-16 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
US20050025824A1 (en) * 2001-12-14 2005-02-03 Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form
AU2002364212B2 (en) * 2001-12-21 2007-09-20 Shire Laboratories Inc. Oral capsule formulation with increased physical stability
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US20080220074A1 (en) * 2002-10-04 2008-09-11 Elan Corporation Plc Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
RU2221559C1 (ru) * 2002-11-15 2004-01-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Препарат диклофенак натрия длительного действия
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
KR101192722B1 (ko) 2003-04-24 2012-10-18 자고텍 아게 정해진 핵 위치를 가지는 서방성 정제
MXPA06003101A (es) * 2003-09-19 2006-06-20 Penwest Pharmaceuticals Co Formas de dosis cronoterapeuticas.
EA200600598A1 (ru) * 2003-09-19 2006-08-25 Пенвест Фармасьютикалз Ко. Лекарственные формы замедленного высвобождения
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
RU2267318C1 (ru) * 2004-05-25 2006-01-10 Закрытое акционерное общество "ФАРМАПЭК" Пролонгированный антиангинальный препарат изосорбида динитрата и способ его получения
ITMI20041295A1 (it) 2004-06-25 2004-09-25 Cosmo Spa Composizioni farmaceutiche antimicrobiche orali
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
JP4916163B2 (ja) * 2004-12-01 2012-04-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 カプセル用コーティング剤
WO2006063078A2 (en) * 2004-12-08 2006-06-15 Elan Corporation, Plc Topiramate pharmaceuticals composition
US20070298098A1 (en) * 2005-02-16 2007-12-27 Elan Pharma International Limited Controlled Release Compositions Comprising Levetiracetam
KR20080007586A (ko) * 2005-04-12 2008-01-22 엘란 파마 인터내셔널 리미티드 세균감염증의 치료를 위한 세팔로스포린 함유 조절 방출조성물
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
WO2006122069A2 (en) * 2005-05-09 2006-11-16 Azur Pharma Formulations of mast cell stabilizing agents for delivery to the colon
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
US20070020333A1 (en) * 2005-07-20 2007-01-25 Chin-Chih Chiang Controlled release of hypnotic agents
WO2007016563A2 (en) * 2005-08-01 2007-02-08 Alpharma Inc. Alcohol resistant pharmaceutical formulations
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
EP1948132B1 (en) 2005-11-18 2009-08-05 Synhton B.V. Zolpidem tablets
MX2009001248A (es) 2006-08-03 2009-02-11 Nitec Pharma Ag Tratamiento con glucocorticoide de liberacion prolongada de enfermedad reumatoide.
CA2673465A1 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US8486452B2 (en) * 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
FR2920431B1 (fr) 2007-08-29 2010-03-12 Essilor Int Procede de preparation d'un materiau transparent de type alliage de polymere thermodurcissable/polymere thermoplastique et son application dans l'optique pour la fabrication de verres organiques.
FR2920337B1 (fr) 2007-08-29 2010-03-12 Essilor Int Procede de preparation d'un article moule transparent a base d'un alliage de polymere thermoplastique et de polymere thermodurcissable
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
US20150164920A1 (en) 2012-03-30 2015-06-18 Laboratorios Del Dr. Esteve S.A. Controlled release formulation comprising mesalamine
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
GB201420311D0 (en) * 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Pharmaceutical processing
GB201420306D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Compositions
GB201420300D0 (en) 2014-11-14 2014-12-31 Bio Images Drug Delivery Ltd Tablet
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US11504327B1 (en) 2019-01-21 2022-11-22 Eric Morrison Method of preparing nanoparticles by hot-melt extrusion
WO2024112807A1 (en) * 2022-11-21 2024-05-30 MORRISON Eric Nanoparticle dispersions comprising therapeutic agents

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341563A (en) * 1978-11-17 1982-07-27 Sankyo Company Limited Protective coating compositions
US4483847A (en) * 1980-06-28 1984-11-20 Warner-Lambert Company Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material
EP0195476A2 (en) * 1985-03-21 1986-09-24 The Procter & Gamble Company Therapeutic particles

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2373763A (en) * 1941-11-24 1945-04-17 State Of Iowa Enteric coating
DE1482489A1 (de) * 1965-01-13 1970-03-12 Boehringer Mannheim Gmbh Vollautomatisches Dragierverfahren
US3438797A (en) * 1965-10-21 1969-04-15 Jerry Allen Biddle Sr Method of preparing pharmaceutical tablets
FR2284318A1 (fr) * 1974-09-13 1976-04-09 Rech Ind Therapeutiqu Compositions d'antibiotiques du type virginiamycine pour administration orale
GB1594102A (en) * 1977-09-26 1981-07-30 Sankyo Co Ingestible coating compositions
JPS54143518A (en) * 1978-04-26 1979-11-08 Shin Etsu Chem Co Ltd Method for producing coating composition for solid preparation
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS56140915A (en) * 1980-04-07 1981-11-04 Yamanouchi Pharmaceut Co Ltd Pharmaceutical preparation for solid drug
US4347237A (en) * 1981-03-02 1982-08-31 Evenstad Kenneth L Lower fatty acid glyceride high-HLB lubricating suppository and method for making and using the same
US4609543A (en) * 1983-11-14 1986-09-02 Nabisco Brands, Inc. Soft homogeneous antacid tablet
JPS60169416A (ja) * 1984-02-14 1985-09-02 Taisho Pharmaceut Co Ltd 素錠の表面処理方法
US5023108A (en) * 1986-01-13 1991-06-11 Research Corporation Aqueous dispersions of waxes and lipids for pharmaceutical coating
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341563A (en) * 1978-11-17 1982-07-27 Sankyo Company Limited Protective coating compositions
US4483847A (en) * 1980-06-28 1984-11-20 Warner-Lambert Company Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material
EP0195476A2 (en) * 1985-03-21 1986-09-24 The Procter & Gamble Company Therapeutic particles

Also Published As

Publication number Publication date
NO912607L (no) 1992-01-06
HUT59591A (en) 1992-06-29
FI109874B (fi) 2002-10-31
PT98188A (pt) 1992-05-29
IE61651B1 (en) 1994-11-16
US5629017A (en) 1997-05-13
LU87964A1 (fr) 1992-03-03
CA2044398A1 (en) 1992-01-05
HU211936A9 (en) 1996-01-29
GR1002564B (el) 1997-02-03
CH683498A5 (fr) 1994-03-31
GB2245492A (en) 1992-01-08
JPH0624961A (ja) 1994-02-01
CA2044398C (en) 2000-07-18
ATA131091A (de) 1995-04-15
IL98525A0 (en) 1992-07-15
NL9101161A (nl) 1992-02-03
RU2012330C1 (ru) 1994-05-15
SE9102072D0 (sv) 1991-07-03
AU8019991A (en) 1992-01-09
FI913248A0 (fi) 1991-07-04
AT400295B (de) 1995-11-27
BE1004882A3 (fr) 1993-02-16
AU638583B2 (en) 1993-07-01
DK129591D0 (da) 1991-07-03
US5445828A (en) 1995-08-29
GB2245492B (en) 1994-03-02
FI913248L (fi) 1992-01-05
ES2036457B1 (es) 1994-03-01
GR910100283A (el) 1992-08-26
GB9114363D0 (en) 1991-08-21
HU912266D0 (en) 1991-12-30
FR2664163B1 (fr) 1995-06-09
DE4122039A1 (de) 1992-01-09
SE512373C2 (sv) 2000-03-06
SE9102072L (sv) 1992-01-05
PT98188B (pt) 1998-12-31
DK129591A (da) 1992-01-05
IE911978A1 (en) 1992-01-15
US5310558A (en) 1994-05-10
NO912607D0 (no) 1991-07-03
IL98525A (en) 1996-07-23
NO304579B1 (no) 1999-01-18
FR2664163A1 (fr) 1992-01-10

Similar Documents

Publication Publication Date Title
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
PT656204E (pt) Comprimido farmaceutico de libertacao controlada possuindo forma lenticular
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
IT8719064A0 (it) Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive.
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
ES2051698T3 (es) Granulos destinados a permanecer en el estomago.
PT1140012E (pt) Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
AR002009A1 (es) Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
ES537022A0 (es) Un procedimiento para la preparacion de una formulacion medicamentosa para inyeccion intravenosa.
DE69009769D1 (de) Arzneimittel mit gesteuerter wirkstoffreisetzung.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
ATE66371T1 (de) Arzneimittelzubereitung mit verzoegerter freisetzung.
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
DE69512638D1 (de) Schnell auflösende orale darreichungsform
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
MX9203615A (es) Composicion farmaceutica en forma de polvo para administracion nasal.
ATE29878T1 (de) Pharmazeutisch wirksame verbindungen und deren herstellung.
IT1196190B (it) Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno
MX9301189A (es) Forma de administracion farmaceutica, solida, finamente dividida, para administracion oral, disuelta o suspendida en un liquido farmaceuticamente aceptable y procedimiento para su preparacion.
ES8705223A1 (es) Procedimiento para la obtencion de una composicion retardada a base de bromocriptina.
JPS5721316A (en) Plaster
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20110822